PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.95%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-24.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-64.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-34.02%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-34.71%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-31.31%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.27%
Slight or no buybacks while 1177.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.55%
Reduced diluted shares while 1177.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
67.69%
OCF growth of 67.69% while 1177.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
45912.08%
FCF growth of 45912.08% while 1177.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
98192.55%
10Y revenue/share CAGR above 1.5x 1177.HK's 141.11%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
489.72%
5Y revenue/share CAGR above 1.5x 1177.HK's 7.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
115.01%
Positive 3Y CAGR while 1177.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
248.29%
OCF/share CAGR of 248.29% while 1177.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
342.41%
Positive OCF/share growth while 1177.HK is negative. John Neff might see a comparative advantage in operational cash viability.
596.77%
3Y OCF/share CAGR of 596.77% while 1177.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1844.27%
Positive 10Y CAGR while 1177.HK is negative. John Neff might see a substantial advantage in bottom-line trajectory.
168.03%
Positive 5Y CAGR while 1177.HK is negative. John Neff might view this as a strong mid-term relative advantage.
155.77%
Positive short-term CAGR while 1177.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
-4.80%
Negative equity/share CAGR over 10 years while 1177.HK stands at 737.64%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
3.97%
Below 50% of 1177.HK's 189.72%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
35.34%
3Y equity/share CAGR above 1.5x 1177.HK's 10.75%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-94.27%
Cut dividends over 10 years while 1177.HK stands at 1558.16%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.27%
Inventory growth of 5.27% while 1177.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-61.88%
Negative asset growth while 1177.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-100.00%
We have a declining book value while 1177.HK shows 30.98%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
15.45%
We have some new debt while 1177.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
4.08%
We expand SG&A while 1177.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.